#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Chronic myelomonocytic leukaemia Desmoplastic small round cell tumour Non-Hodgkin's lymphoma Wiskott-Aldrich syndrome Squamous cell carcinoma of the hypopharynx Haemophilia A without inhibitors Autoinflammation with infantile enterocolitis Round cell liposarcoma Thymic carcinoma Antiphospholipid syndrome B-cell lymphoma recurrent Ichthyosis Liposarcoma recurrent Cerebral arteriovenous malformation haemorrhagic More trials…

    Learn about Rare Diseases

    Nephroblastoma – Life with Disease Idiopathic inflammatory myopathy – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease Alagille syndrome – Basic Information Turner’s syndrome – Life with Disease Leiomyosarcoma recurrent – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) Rhabdomyosarcoma – Treatment Hepatic angiosarcoma – Trials in Disease Fabry’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexibuprofen Methoxyflurane Tretinoin Nacubactam Vedolizumab Colesevelam Calcium Levofolinate Chlorhexidine Dihydrochloride Wve-006 Sodium Phenylbutyrate Isis 678354 Sodium Salt Ixazomib Citrate Triptorelin Tisagenlecleucel Vilobelimab Azetukalner Ide397 Docetaxel Carfilzomib ZILUCOPLAN More therapies…

    Learn about Your Condition

    Schizophrenia Urethral valves Langerhans' cell histiocytosis Vomiting Coagulopathy Ulcerative keratitis Adenovirus infection Intervertebral disc protrusion Adrenogenital syndrome Postoperative wound infection Giant cell arteritis Diverticulitis Osteopenia Brain stem glioma Gastric cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thymic carcinoma
    • Thymoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    France Italy Spain

  • Study Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    Investigated Drugs:
    • Mitomycin
    • Capecitabine
    • Cisplatin
    France

  • Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin
    • Abemaciclib
    • Giredestrant
    Austria Belgium Finland France Germany Greece +7

  • Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
    • Sunitinib
    Czechia Denmark France Germany Hungary Italy +5

  • Study of Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pembrolizumab
    Denmark France Germany Italy The Netherlands Norway +3

  • Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Antiemetics And Antinauseants
    • Antipsychotics
    • Capecitabine
    Austria Belgium Czechia France Germany Greece +5

  • Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Olaparib
    Denmark France Hungary Italy Spain

  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    • Ependymoma
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Capecitabine
    • Cyclophosphamide
    • Nivolumab
    France

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany
Previous Page
1 … 23 24 25 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!